[Current indications for implantable automatic defibrillators].
Since the first implantation in man in 1980 implantable cardioverter defibrillator technology has greatly improved and the number of devices implanted has increased considerably in recent years. Non-thoracotomy lead systems and biphasic shocks are now the approach of choice, offering nearly a 100% success rate. This paper version reviews the current indications for the implantation of implantable cardioverter defibrillator and is an upgraded of an article previously published by the Arrhythmia's Section of the Spanish Society of Cardiology. Recommendations for qualification of centres implanting defibrillators and follow up are also addressed.
Villacastín
J
J
Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid.
Hernández Madrid
A
A
Moya
A
A
Peinado
R
R
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D009202:Cardiomyopathies / Q000150:complications; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003327:Coronary Disease / Q000150:complications; D003645:Death, Sudden / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D011322:Primary Prevention; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors; D013610:Tachycardia / Q000628:therapy; D014693:Ventricular Fibrillation / Q000628:therapy
D000889:Anti-Arrhythmia Agents
Indicaciones actuales del desfibrilador automático implantable.